Beijing Med-Pharm Inks Deal With KV Pharmaceutical To Bring Clindesse To China
This article was originally published in The Pink Sheet Daily
Executive Summary
Marketing and distribution firm will be responsible for completing late-stage clinical development and registration of clindamycin.